|
|
卵巢早衰的诊治与早期预警研究现状 |
肖红梅, 王乐 |
中南大学基础医学院生殖与干细胞工程研究所/生殖健康研究中心,湖南 长沙 410078 |
|
[1] 陈子江,田秦杰,乔杰,等, 早发性卵巢功能不全的临床诊疗中国专家共识[J].中华妇产科杂志, 2017, 52(9): 577-581. [2] De Vos M, Devoroey P, Fauser BC. Primary ovarian insufficiency[J].Lancet,2010, 376(9477):911-921. [3] Committee on Gynecologic Practice. Committee opinion No. 698: hormone therapy in primary ovarian insufficiency[J].Obstet Gynecol,2017,129(5):e134-e141. [4] European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, et al. ESHRE Guideline: management of women with premature ovarian insufficiency[J].Hum Reprod,2016,31(5):926-937. [5] Elkheir EAH. Autologous stem cell transplantation in patients with idiopathic premature ovarian failure[J].J Tissue Sci Eng,10.4172/2157-7552.C1.030. [6] Kawamura K, Kawamura N, Hsueh AJ. Activation of dormant follicles: a new treatment for premature ovarian failure[J].Curr Opin Obstet Gynecol,2016,28(3):217-222. [7] Sheikhansari G, Aghebati-Maleki L, Nouri M, et al. Current approaches for the treatment of premature ovarian failure with stem cell therapy[J].Biomed Pharmacother,2018,102:254-262. [8] Jadoul P. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases[J].Hum Reprod,2017,32(5):1046-1054. [9] Lunding SA, Pors SE, Kristensen SG, et al. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve[J].Hum Reprod,2019,34(10):1924-1936. [10] Jiao X, Ke H, Qin Y, Chen ZJ. Molecular Genetics of Premature Ovarian Insufficiency[J].Trends Endocrinol Metab,2018 ,29(11):795-807. [11] Rudnicka E, Kruszewska J, Klicka K, et al. Premature ovarian insufficiency - aetiopathology, epidemiology, and diagnostic evaluation[J].Prz Menopauzalny,2018,17(3):105-108. [12] Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte[J].Hum Reprod,2003,18(1):117-121. [13] Spears N, Lopes F, Stefansdottir A, et al. Ovarian damage from chemotherapy and current approaches to its protection[J].Hum Reprod Update,2019,25(6):673-693. [14] Delkhosh A, Delashoub M, Tehrani AA, et al. Upregulation of FSHR and PCNA by administration of coenzyme Q10 on cyclophosphamide-induced premature ovarian failure in a mouse model[J].J Biochem Mol Toxicol,2019,33(11):e22398. [15] Huang B, Ding C, Zou Q, et al. Cyclophosphamide Regulates N6-Methyladenosine and m6A RNA Enzyme Levels in Human Granulosa Cells and in Ovaries of a Premature Ovarian Aging Mouse Model[J].Front Endocrinol (Lausanne),2019,10:415. [16] Domniz N, Meirow D. Premature ovarian insufficiency and autoimmune diseases[J].Best Pract Res Clin Obstet Gynaecol,2019,60:42-55. [17] Zhu D, Chung HF, Pandeya N, et al. Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies[J].PLoS Med,2018,15(11):e1002704. [18] Alipour F, Rasekhjahromi A, Maalhagh M, et al. Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure[J].Dis Markers,2015,2015:585604. [19] Knauff EA, Eijkemans MJ, Lambalk CB, et al. Dutch Premature Ovarian Failure Consortium. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure[J].J Clin Endocrinol Metab,2009,94(3):786-792. [20] Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, et al. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study[J].Hum Reprod,2018,33(6):1175-1182. [21] Dólleman M, Verschuren WM, Eijkemans MJ, et al. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study[J].J Clin Endocrinol Metab,2013 ,98(5):2106-2115. [22] Matikainen T, Perez GI, Jurisicova A, et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals[J].Nat Genet,2001,28(4):355-360. [23] Kim CW. Effects of cigarette smoke extracts on apoptosis and oxidative stress in two models of ovarian cancer in vitro[J].Toxicol In Vitro,2018,52:161-169. [24] Taneri PE, Kiefte-de Jong JC, Bramer WM, et al. Association of alcohol consumption with the onset of natural menopause: a systematic review and meta-analysis[J].Hum Reprod Update,2016,22(4):516-528. |
[1] |
陈艳, 王芳. 声诺维经阴道子宫输卵管超声造影结合CDFI检查对输卵管源性不孕症的诊断价值[J]. 医学临床研究, 2020, 37(10): 1575-1576. |
[2] |
贺伊, 李文. 原发性卵巢功能不全的遗传学病因研究进展[J]. 医学临床研究, 2020, 37(6): 807-809. |
[3] |
谷雪, 赵淑萍. 来曲唑治疗多囊卵巢综合征不孕症患者的疗效观察[J]. 医学临床研究, 2020, 37(5): 759-760. |
[4] |
郁平, 姬小凡, 王敏, 徐晓艳. BMP-15、sRAGE、MMP9在PCOS患者卵泡液中表达及其与卵子质量的相关性分析[J]. 医学临床研究, 2020, 37(3): 382-384. |
[5] |
刘守福, 阳袁莉, 蒋艳, 黎雪梅, 汪琼英. 单孔腹腔镜手术治疗卵巢囊肿的疗效观察[J]. 医学临床研究, 2020, 37(3): 403-405. |
[6] |
刘铭兰, 施尉红. 减量降调长方案治疗卵巢储备功能低下患者的临床疗效[J]. 医学临床研究, 2019, 36(12): 2465-2466. |
[7] |
丁霞, 潘长青. 来曲唑联合HCG治疗多囊卵巢综合征患者的疗效观察[J]. 医学临床研究, 2019, 36(6): 1044-1046. |
[8] |
于峰, 秦秀云, 张雪梅, 付超. 滋肾化痰助孕汤联合坤泰胶囊治疗多囊卵巢综合征52例疗效观察[J]. 医学临床研究, 2019, 36(6): 1162-1164. |
[9] |
王新焘. 超声刀在卵巢囊肿手术中应用对患者近期生殖激素、卵巢血流的影响[J]. 医学临床研究, 2019, 36(5): 1033-1034. |
[10] |
杨林林, 魏明华, 张书宜, 徐艳琦, 崔社娟. 基于多平面重组CT卵巢静脉追踪对卵巢源肿物的诊断价值[J]. 医学临床研究, 2019, 36(4): 699-701. |
[11] |
尹森花, 王瑞玲. 炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征的疗效观察[J]. 医学临床研究, 2019, 36(1): 126-128. |
[12] |
马艳茹, 陆晓媛. 抗苗勒管激素联合性激素水平检测在多囊卵巢综合征患者促卵泡发育治疗中的预测价值[J]. 医学临床研究, 2018, 35(11): 2175-2177. |
[13] |
黄慧娟. 多囊卵巢综合征不孕患者性激素与外周血NK细胞活性的关系[J]. 医学临床研究, 2018, 35(10): 1987-1988. |
[14] |
邓轩宇. 葛根素注射液联合炔雌醇环丙孕酮治疗多囊卵巢综合征不孕患者的疗效观察[J]. 医学临床研究, 2018, 35(7): 1388-1390. |
[15] |
邹茂贤, 麦洁兰, 罗燕飞, 蒋静文. 多囊卵巢综合征患者血清可溶性CD163的表达水平及其与代谢参数的关系[J]. 医学临床研究, 2018, 35(7): 1398-1399. |
|
|
|
|